Christine Blank
$96.5 Million Generic Payout Latest Trouble for Mylan
A $96.5 million settlement is the latest in a series of pricing and competition issues Mylan has faced in the past year.
How New Biosimilars Will Impact the Market
More biosimilars are coming onto the market , including competitors for Remicade and Neulasta.
How Pharmacists Are Helping Patients with Diabetes in a Rural Area
A study has found that patients with diabetes at a rural clinic have improved health outcomes when they are managed by a pharmacist diabetes clinic.
Three New Digital Tools for People with Diabetes
People with diabetes and health-care professionals have more options for managing their care as more companies create high-tech tools for them. Now, three recently-launched tools and apps will provide more help to pharmacists so that they can help people with diabetes in managing their disease.
Hepatitis C screening recommended by CMS for some beneficiaries
The Centers for Medicare and Medicaid Services (CMS) is accepting public comments until April 3 on its new hepatitis C screening guidelines.
Insulin pumps outperform injections in diabetic children
Insulin pumps control blood sugar in children with diabetes better than insulin injections, according to a new study.
One in 10 Americans have taken someone else’s Rx
One in 10 Americans admit taking someone else’s Rx, according to an ongoing Reuters/psos online survey. About a quarter of those people used the prescription drugs to get high, according to the survey.
SPAARx protests rules on refill reminders, marketing
The Specialty Pharmacy Association of America is concerned about the language involving refill reminders and marketing in the U.S. Department of Health and Human Services’ newly released revisions to HIPAA concerning the HITECH Act.
NABP study says rogue websites are rampant
Nearly all prescription drug websites geared toward Americans are operating out of compliance with U.S. pharmacy laws, according to a study by the National Association of Boards of Pharmacy.

Poll